Announcements Trials
Browse Landscape

Phase

Phase 1/2 4Phase 1 2Phase NA 1Phase EARLY_PHASE1 1

Status

Completed 4

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Sarcoma 1Other hematologic neoplasm 1Myeloid 1Genitourinary 1Gastrointestinal 1

Conditions

Sarcoma 1Myelodysplastic Syndromes 1Metastasis From Malignant Tumor of Kidney (Disorder) 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Colorectal Neoplasms 1

Interventions

Cyclophosphamide 250Radiotherapy 172pembrolizumab 154Carboplatin 146Gemcitabine 139Nivolumab 135Paclitaxel 129Dexamethasone 118Cisplatin 118fludarabine 115Rituximab 104Lenalidomide 103Bevacizumab 99Docetaxel 97Capecitabine 97fludarabine phosphate 92Temozolomide 89Cytarabine 89Oxaliplatin 87Etoposide 82Filgrastim 77Irinotecan 73Doxorubicin 73venetoclax 70Peripheral Blood Stem Cell Transplantation 68Fluorouracil 68Radiosurgery 66Melphalan 66Everolimus 66Bortezomib 66

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1/2 × OTHER × Immunotherapy, Active × Clear all
NCT03357276 2019-09-12

Mix Vaccine for Metastatic Colorectal Cancer

Fuda Cancer Hospital, Guangzhou

Phase 1/2 Completed
30 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT03357289 2019-09-12

Mix Vaccine for Metastatic Kidney Cancer

Fuda Cancer Hospital, Guangzhou

Phase 1/2 Completed
30 enrolled
Genitourinary

Metastasis From Malignant Tumor of Kidney (Disorder)

NCT03357315 2019-09-12

Mix Vaccine for Metastatic Sarcoma Patients

Fuda Cancer Hospital, Guangzhou

Phase 1/2 Completed
30 enrolled
Sarcoma

Sarcoma

NCT01819558 2015-03-20

ALLO-WT1

Institut Paoli-Calmettes

Phase 1/2 Completed
2 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡